(Q34202664)

31 July 2017

1 reference

title

Digitalis for treatment of congestive heart failure in patients in sinus rhythm. (English)

1 reference

31 July 2017

Digitalis for treatment of congestive heart failure in patients in sinus rhythm (English)

0 references

1 reference

congestive heart failure

1 reference

3

G H Guyatt

1 reference

31 July 2017

4

R Jaeschke

1 reference

31 July 2017

W B Hood

1

1 reference

31 July 2017

A Dans

series ordinal

2

1 reference

31 July 2017

J V McMurray

series ordinal

5

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

Cochrane Database of Systematic Reviews

31 July 2017

2001

0 references

published in

1 reference

31 July 2017

CD002901

1 reference

31 July 2017

1

1 reference

Need for a large randomized trial to evaluate the effects of digitalis on morbidity and mortality in congestive heart failure

31 July 2017

3

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Effect of maintenance digoxin therapy on aerobic performance and exercise left ventricular function in mild to moderate heart failure due to coronary artery disease: a randomized, placebo-controlled, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Nonpharmacologic therapy improves functional and emotional status in congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Effect of digitalis treatment on survival after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

The functional defect in amyloid heart disease. The "stiff heart" syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Digoxin. A neurohormonal modulator in heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Cardiac glycosides in the next millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Initial blood pressure response to enalapril in hospitalized patients (Studies of Left Ventricular Dysfunction [SOLVD]).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

To what extent do congestive heart failure patients in sinus rhythm benefit from digoxin therapy? A systematic overview and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Is maintenance digoxin necessary in patients with sinus rhythm?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Favorable effects of orally administered digoxin on left heart size and ventricular wall motion in patients with previous myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Can physicians always explain the results of clinical trials? A case study of amlodipine in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

The effect of digoxin on mortality and morbidity in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Is digoxin really important in treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

A controlled trial of digoxin in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Heart failure in outpatients: a randomized trial of digoxin versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Digoxin Withdrawal After Cardiac Failure in Patients with Sinus Rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Long-term digitalis therapy improves left ventricular function in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Association of digitalis therapy with mortality in survivors of acute myocardial infarction: observations in the Beta-Blocker Heart Attack Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Maintenance Digoxin in Elderly Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Digoxin in eurhythmic heart failure: PROVED or "not proven"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Effect of chronic oral digoxin therapy on ventricular function at rest and peak exercise in patients with ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

The efficacy of digitalis withdrawal in an institutional aged population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Effects of discontinuing maintenance digoxin therapy in patients with ischemic heart disease and congestive heart failure in sinus rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Digitalis-associated cardiac mortality after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Blind study on the action of digitoxin on elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Differences in drug treatment of chronic heart failure between European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

Short- and long-term effects of digitalis on resting and posthandgrip hemodynamics in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002901

10.1002/14651858.CD002901

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference